人工视网膜市场规模、份额、成长分析，按产品类型、按应用、按地区 - 按行业预测 - 2024-2031

2022年全球视网膜假体市场规模为52亿美元，从2023年的64.8亿美元成长到2031年的376.4亿美元，复合年增长率预计将成长24.6%。

由于医疗技术的进步和视网膜疾病盛行率的上升，全球视网膜假体市场预计将大幅成长。视网膜假体（视网膜人工替代物）是一种创新设备，旨在帮助患有色素性视网膜炎和老龄化黄斑部病变等疾病的患者恢復视力。对有效治疗的需求激增是由技术创新所推动的，这些技术创新增加了这些系统的功能，例如无线通讯和电极设计的改进。研发投资、政府措施和有利的报销计画进一步支持市场扩张。虽然北美在工业巨头的支持和先进技术的引进下占据市场主导地位，但由于医疗保健投资的增加和对视网膜健康问题认识的提高，亚太地区有望实现显着增长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

人工视网膜市场规模：依产品类型及复合年增长率（2024-2031）

• 市场概况
• 视网膜前植入
• 视网膜下植入
• 其他的

人工视网膜市场规模：依应用与复合年增长率（2024-2031）

• 市场概况
• 老龄化黄斑部病变（AMD）
• 色素性视网膜炎

人工视网膜市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
• 产品系列分析
• 按细分市场分類的份额分析
• 收益与前一年同期比较（2021-2023）

主要企业简介

• Pixium Vision
• Axorus
• Intelligent Medical Implants
• LambdaVision, Inc.
• Nidek Co. Ltd.
• Nano Retina
• Bionic Vision Technologies
• Optobionics
• Medtronic
• Vivani Medical Inc.
• Labtician Ophthalmics, Inc.
• Retina Implant AG
• Altris, Inc.
• Second Sight Medical Applications, Inc.
• Neurotech Pharmaceuticals
• iBIONICS
• RenovaCare, Inc.
• Okuvision GmbH
• VisionCare, Inc.

结论和建议

Global Artificial Retina Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.48 billion in 2023 to USD 37.64 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global Artificial Retina Market is poised for remarkable growth due to advancements in medical technology and the rising incidence of retinal diseases. Artificial retinas, or retinal prostheses, are innovative devices aimed at restoring vision for those suffering from conditions like retinitis pigmentosa and age-related macular degeneration. This surge in demand for effective treatments is bolstered by technological innovations, including wireless communication and improved electrode designs, enhancing the functionality of these systems. Investments in R&D, government initiatives, and favorable reimbursement frameworks further drive market expansion. North America dominates the market, underpinned by major industry players and adoption of advanced technologies, while the Asia-Pacific region is set for significant growth due to increasing healthcare investments and awareness of retinal health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Retina market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Retina Market Segmental Analysis

Global Artificial Retina Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Epiretinal Implants, Subretinal Implants, and Others. Based on Application, the market is segmented into Age-Related Macular Degeneration (AMD), and Retinitis Pigmentosa. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Retina Market

A significant factor propelling the Global Artificial Retina Market is the rising incidence of retinal diseases. Conditions like retinitis pigmentosa, age-related macular degeneration, and diabetic retinopathy are becoming more common, driving demand for innovative artificial retina technologies. As the global population ages and the prevalence of chronic illnesses escalates, there is an increasing need for effective solutions to restore vision for those affected by retinal diseases. This urgent demand for advanced treatment options contributes to the overall growth and expansion of the artificial retina market, highlighting the critical role it plays in addressing these challenging health issues.

Restraints in the Global Artificial Retina Market

One significant limitation in the Global Artificial Retina market is the prohibitive cost associated with both the devices and the related procedures. The intricate and advanced technology involved in creating artificial retina systems, along with the substantial expenses tied to research, development, manufacturing, and obtaining regulatory approvals, leads to elevated pricing of these implants. This issue of affordability and accessibility hampers widespread adoption, particularly in areas where healthcare resources are scarce or where income levels are lower. As a result, the high costs present a considerable obstacle to market expansion, especially in developing regions and for patients facing financial constraints.

Market Trends of the Global Artificial Retina Market

The Global Artificial Retina Market is witnessing a significant trend towards miniaturization and integration of wireless communication technologies. As advancements in materials and engineering techniques progress, manufacturers are focusing on developing more compact, lightweight artificial retina devices that promise easier implantation and greater patient comfort. This movement is complemented by an emphasis on incorporating wireless features, enabling seamless data transfer and efficient remote monitoring, which paves the way for potential system upgrades and enhancements in functionality. This trend not only aims to enhance the user experience but also seeks to advance the clinical capabilities and overall effectiveness of artificial retina systems, driving innovation in the field.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Artificial Retina Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Epiretinal Implants
• Subretinal Implants
• Others

Global Artificial Retina Market Size by Application & CAGR (2024-2031)

• Market Overview
• Age-Related Macular Degeneration (AMD)
• Retinitis Pigmentosa

Global Artificial Retina Market Size & CAGR (2024-2031)

• North America, (Product Type, Application)
  • US
  • Canada
• Europe, (Product Type, Application)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pixium Vision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axorus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intelligent Medical Implants
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LambdaVision, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Retina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionic Vision Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optobionics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivani Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labtician Ophthalmics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Retina Implant AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altris, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Second Sight Medical Applications, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurotech Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iBIONICS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RenovaCare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okuvision GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VisionCare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation